Please log in to determine if you are eligible to purchase PT Programs.
HUMAN PAPILLOMAVIRUS, MIXED MEDIA - CHPVJ
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Challenges per Shipment
Number of Shipments
Three shipments per year
High‑risk HPV genotyping (optional)
Each laboratory should choose the Survey that best reflects the transport media received in its facility. For Survey CHPVJ, participants must provide results for all three media types.
For laboratories that perform HPV genotyping using ThinPrep PreservCyt Transport medium on site, Survey CHPVM and select samples of Survey CHPVJ provide an opportunity to report specific HPV genotypes.
The CAP does not report genotyping responses to the CMS.
Five simulated cervical specimens
Combination of Digene, ThinPrep PreservCyt, and SurePath transport mediums